Skip to main content
Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
53.54
-1.09 (-2.00%)
At close: Nov 4, 2024, 4:00 PM
53.75
+0.21 (0.39%)
After-hours: Nov 4, 2024, 7:55 PM EST

Moderna Revenue by Segment
Period Ending Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Product Sales Revenue
4.90B 5.01B 6.67B 8.77B 10.14B 14.37B 18.47B 20.51B
Product Sales Revenue Growth
-51.65% -65.15% -63.88% -57.23% -54.34% -34.27% 4.50% 87.49%
Grant and Collaboration Revenue
149.00M - 177.00M 384.00M 554.00M 721.00M 828.00M 879.00M
Grant and Collaboration Revenue Growth
-73.10% - -78.62% -56.31% -30.23% -1.64% 4.02% -1.26%

Product Sales by Geography
Period Ending Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
United States Revenue
1.98B 1.82B 1.72B 1.94B 2.01B 3.46B 4.41B
United States Revenue Growth
-1.69% -47.44% -60.95% - - - -
Rest of World Revenue
2.21B 2.41B 3.60B 3.84B 4.19B 5.65B 7.30B
Rest of World Revenue Growth
-47.31% -57.24% -50.70% - - - -
Europe Revenue
- - 1.35B 2.96B 3.90B 5.23B 6.73B
Europe Revenue Growth
- - -79.90% - - - -

Operating Expense Breakdown
Period Ending Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Research and Development
4.85B 4.78B 4.85B 4.65B 4.31B 3.87B 3.30B 2.73B
Research and Development Growth
12.53% 23.37% 47.04% 70.20% 77.15% 80.60% 65.49% 29.98%
Selling, General, and Administrative
1.45B 1.52B 1.55B 1.45B 1.29B 1.17B 1.13B 958.00M
Selling, General, and Administrative Growth
12.71% 29.85% 36.84% 51.77% 52.12% 54.22% 99.65% 115.41%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.